OSCR

TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway.

Overview

Authors: Yuichiro Kai1, Akito Tsuruta1, Takuto Inoki1, Tomoaki Yamauchi1, Shigehiro Ohdo2, Satoru Koyanagi1
  1. Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
  2. Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
Institutions: Kyushu University (Japan)
Journal: The Journal of biological chemistry, volume 302, issue 10, article 113447
Dates: received 12 February 2026; published online 13 August 2026; in print August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1016/j.jbc.2026.113447 · PMID 42595109 · PMCID PMC13579946 · OpenAlex W7202367145
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics, Connectivity
Keywords: glioma, clock gene, TIMELESS, cancer stem cells, JAK-STAT3
Topic: Circadian rhythm and melatonin (Endocrine and Autonomic Systems, Neuroscience), according to OpenAlex
Funding: Japan Society for the Promotion of Science (25K02425, 25K10469, 25K23692, 23K14569); Japan Agency for Medical Research and Development (JP26am121031); Japan Science and Technology Agency (JPMJSP2136)
Citations: not cited yet (Europe PMC); 48 references in the paper
Research resources: GAPDH RRID:AB_10622025, KLF4 RRID:AB_10640807, RRID:AB_10679369, STAT3 Phospho (Tyr705 RRID:AB_10897947, c-MYC RRID:AB_2148585, p84 RRID:AB_2202239, OCT4 RRID:AB_2561766, STAT3 RRID:AB_2861053, RRID:AB_2882337, SOX2 RRID:AB_355110, JAK1 RRID:AB_627836, HRP-conjugated anti-goat IgG antibody RRID:AB_631728, HRP-conjugated anti-mouse IgG antibody RRID:AB_955438, RRID:CVCL_0021, RRID:CVCL_ZJ44, RRID:SCR_003070

Abstract

Gliomas are the most common primary tumors of the central nervous system. Among them, glioblastoma (GBM), a World Health Organization (WHO) grade 4 glioma, is the most aggressive form and remains one of the most lethal human cancers. Its poor prognosis is largely attributable to rapid progression, frequent recurrence, and profound therapeutic resistance, all of which are closely associated with glioma stem cells (GSCs). Although several signaling pathways sustaining GSC properties have been identified, upstream regulators that coordinate these pathways remain incompletely understood. TIMELESS, originally identified as a component of the circadian clock, has recently been implicated in the regulation of brain function and is aberrantly overexpressed in multiple cancer types; however, its role in glioma malignancy has not been defined. Here, we demonstrate that TIMELESS mRNA expression increases with glioma grade and is associated with poor prognosis across multiple glioma cohorts. Genetic depletion of Timeless suppressed tumor aggressiveness and prolonged survival in an orthotopic mouse glioma model by attenuating GSC properties. Mechanistically, TIMELESS enhanced stemness of glioma by upregulating Janus kinases (JAK) expression and promoting phosphorylation of signal transducer and activator of transcription 3 (STAT3). These effects were conserved in human GBM cells, supporting the relevance of TIMELESS-mediated signaling across species. Together, our findings uncover an unexpected, clock-independent function of TIMELESS in sustaining glioma stemness and malignancy and highlight the TIMELESS-JAK-STAT3 axis as a noncanonical mechanism that operates beyond the traditional circadian clockwork in treatment-resistant glioma.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

All data supporting the results of the present study are included in the article.

The RNA-seq data generated in this study have been deposited in the Gene Expression Omnibus (GEO) database under accession number GSE336084 (https://ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE336084).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Tomoaki Yamauchi (0009-0001-2598-4566); removed Tomoaki Yamauchi

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 5 keywords, 3 funders, 48 references, 16 RRIDs.

Cite

This paper

Kai, Y., Tsuruta, A., Inoki, T., Yamauchi, T., Ohdo, S., & Koyanagi, S. (2026). TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway. The Journal of biological chemistry, 302(10), 113447. https://doi.org/10.1016/j.jbc.2026.113447

BibTeX

@article{kai2026timeless,
author = {Kai, Yuichiro and Tsuruta, Akito and Inoki, Takuto and Yamauchi, Tomoaki and Ohdo, Shigehiro and Koyanagi, Satoru},
title = {{TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway}},
journal = {The Journal of biological chemistry},
year = {2026},
month = aug,
volume = {302},
number = {10},
pages = {113447},
publisher = {American Society for Biochemistry and Molecular Biology},
issn = {0021-9258},
doi = {10.1016/j.jbc.2026.113447},
url = {https://doi.org/10.1016/j.jbc.2026.113447},
pmid = {42595109},
pmcid = {PMC13579946}
}

RIS

TY - JOUR
AU - Kai, Yuichiro
AU - Tsuruta, Akito
AU - Inoki, Takuto
AU - Yamauchi, Tomoaki
AU - Ohdo, Shigehiro
AU - Koyanagi, Satoru
TI - TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway
T2 - The Journal of biological chemistry
J2 - J Biol Chem
PY - 2026
DA - 2026/08/13
VL - 302
IS - 10
SP - 113447
SN - 0021-9258
PB - American Society for Biochemistry and Molecular Biology
DO - 10.1016/j.jbc.2026.113447
UR - https://doi.org/10.1016/j.jbc.2026.113447
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.jbc.2026.113447",
"type": "article-journal",
"title": "TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway",
"container-title": "The Journal of biological chemistry",
"author": [
{
"family": "Kai",
"given": "Yuichiro"
},
{
"family": "Tsuruta",
"given": "Akito"
},
{
"family": "Inoki",
"given": "Takuto"
},
{
"family": "Yamauchi",
"given": "Tomoaki"
},
{
"family": "Ohdo",
"given": "Shigehiro"
},
{
"family": "Koyanagi",
"given": "Satoru"
}
],
"container-title-short": "J Biol Chem",
"volume": "302",
"issue": "10",
"page": "113447",
"DOI": "10.1016/j.jbc.2026.113447",
"PMID": "42595109",
"PMCID": "PMC13579946",
"ISSN": "0021-9258",
"publisher": "American Society for Biochemistry and Molecular Biology",
"URL": "https://doi.org/10.1016/j.jbc.2026.113447",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
13
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1016/j.jbc.2025.108544
N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2.
Journal: The Journal of biological chemistry
In common: other condition, cellular / molecular, 3 references, 2 authors
[2] doi:10.1158/2767-9764.crc-22-0243
MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.
Journal: Cancer research communications
In common: other condition, cellular / molecular, 4 references
[3] doi:10.3390/cancers15184619
Repurposing Clemastine to Target Glioblastoma Cell Stemness.
Journal: Cancers
In common: other condition, cellular / molecular, 4 references
[4] doi:10.3390/ijms23094511
High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML.
Journal: International journal of molecular sciences
In common: other condition, cellular / molecular, 3 references
[5] doi:10.1186/s12935-026-04213-6
Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells.
Journal: Cancer cell international
In common: other condition, cellular / molecular, 3 references
[6] doi:10.1186/s12915-025-02127-9 [code]
Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets.
Journal: BMC biology
In common: other condition, cellular / molecular, 3 references
[7] doi:10.1126/sciadv.adn1607
Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone.
Journal: Science advances
In common: other condition, 3 references
[8] doi:10.1093/neuonc/noae206
EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma.
Journal: Neuro-oncology
In common: other condition, 2 references
[9] doi:10.1098/rspb.2024.1848 [code]
Uncovering the circadian transcriptome of <i>Nasonia vitripennis</i>: insights into a non-canonical insect model.
Journal: Proceedings. Biological sciences
In common: cellular / molecular, 2 references
[10] doi:10.3389/fphys.2022.873237
It's About Time: The Circadian Network as Time-Keeper for Cognitive Functioning, Locomotor Activity and Mental Health.
Journal: Frontiers in physiology
In common: other condition, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.